Navigation Links
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Date:1/6/2009

Proves significance of AHCC for maintaining a healthy immune system

PURCHASE, N.Y., Jan. 6 /PRNewswire/ -- A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.

The study was conducted in a double-blind randomized fashion where twenty-one healthy subjects received a placebo or AHCC at 3.0 g/day for 4 weeks. Blood samples were obtained and measured at baseline and at 4 weeks. The number of circulating types of DCs was measured which included CD 11c+ DCs (myeloid DC population; DC1) and CD11c- DCs (lymphoid DC population; DC2). Other parameters measured included mixed-leukocyte reaction (MLR), natural killer (NK) cell activity, the proliferative response of T lymphocytes toward mitogen (phytohemagglutinin [PHA]) and cytokine production of interleukin (IL)-2, IL-4, IL-6, IL-10, interferon gamma-gamma, and (alpha)-tumor necrosis factor.

Results demonstrated that the AHCC group (n=10) after intake had a significantly higher number of total DCs compared to baseline and also that of the control (n=11). The number of DC1s in the AHCC group after intake was significantly higher than at baseline. Additionally, the number of DC2s in the AHCC group after intake was significantly increased in comparison with controls. The mixed-leukocyte reaction (MLR) was also significantly increased in comparison with controls. For PHA, NK cell activity and cytokine production no significant differences were found between groups.

"This study shows that AHCC increases production of DCs that are critical for maintaining a healthy and balanced immune system. It also provides insights in understanding
'/>"/>

SOURCE AHCC Research Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...arch report is available in its catalogue. ,, ...: Increasing Adoption to Drive Growth ,, htt...toring-Blood-Glucose-Market-(SMBG )-Increasing-Ado...mp;utm_medium=pr&utm_campaign=prnewswire ,...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...arch report is available in its catalogue. ,, ...009 ,, http://www.reportlinker.com/p0164742/...009.html#utm_source=prnewswire&utm_medium=pr&a...for Assisted Reproduction covers the U.S., 15 Coun...
(Date:11/20/2009)..., , HOUSTON, Nov. 20 /PRNewswire-FirstC...nounced that Dan Moore, President and Chief Execut...cer, will present at the 21st Annual Piper Jaffray...December 2, 2009 at 12:00 PM EST. The conference ...al slides will be presented. Piper Jaffray will h...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 13566 1DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 13566 2DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 13566 3DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 13566 4DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 13566 5MGT Capital Investments Inc Reports Fiscal 2009 Second Quarter Financial Results 54524 1MGT Capital Investments Inc Reports Fiscal 2009 Second Quarter Financial Results 54524 2MGT Capital Investments Inc Reports Fiscal 2009 Second Quarter Financial Results 54524 3Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 1Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 2Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 3Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 4Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 5Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 6Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 7Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 8Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 9Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 10Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 11Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 12Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 54522 13
...ments With ROX-828 In Migraine Pain And R...ENLO PARK, Calif., April 28 ROXRO PHARMA, Inc. to...al study of the company,s,novel investigational in...e,and related symptoms., The placebo-controlled p...afety of ROX-828, an intranasal formulation of the...
...ults, LAUSANNE, Switzerland, April 28 Debiopharm...aceutical development specialist,focusing on serio...ented,positive efficacy results of a phase IIa stu...nhibitor with a potent in-vitro and in-vivo,anti-h... 025 shows an,important additive anti-HCV effect w...
Other Medicine Technology:ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 3Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
(Date:11/22/2009)... control, expert says , , SUNDAY, Nov. 2...,ll be faced with a seemingly endless buffet of fo...d eat too much, others deny themselves any holiday...en overindulgence and deprivation, according to Ju... at Brigham and Women,s Hospital in Boston. She of...
(Date:11/22/2009)...ne post You Tube video demonstrating the Really Co... Landover, MD (PRWEB) November 22, 2009... what a really rugged waterproof keyboard can with...d vs Washable Competitors Keyboard HD” video...ium, Really Cool Keyboard from Man & Machine,...
(Date:11/21/2009)...re-USNewswire/ -- DNC Chairman Tim Kaine issued th...gin full debate of health insurance reform legisla...n/prnh/20080519/DNCLOGO ) ,, "Today, the Sena...ing health insurance reform. By clearing this firs...ortunity to debate the health reform bill on the S...
(Date:11/21/2009)...ire-USNewswire/ -- A regional initiative launched ...indness) in the Americas has substantially reduced... evidenced by a 31% decrease in the number of indi...endemic countries. Results were reported today at...f Tropical Medicine and Hygiene (ASTMH). ,, Th...
(Date:11/21/2009)...l credentialing software company IntelliSoft Group...p with Amerinet, Inc., the leading healthcare G.P....sform quality care within the healthcare market. ...9 -- ISG Group, LLC, doing business as IntelliSoft...t Inc., a leading national healthcare group purcha...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
... shaping (through circumferential reduction) treat...cret , , IRVINE, Calif., March 19 Khloe Kardashi...with the Kardashians , receives the VelaShape(TM) ... 10/9c. , , In the episode, Khloe prepares her ...
...Company will debut a full line up of American-buil...how & America,s Expo for Skin Care & Spa S...Illinois. , , TOLEDO, Ohio, March 19 "With today...ies USA is proud to raise the bar against cross co...
...SHENZHEN, China, March 19 /PRNewswire-Asia-FirstCa..., (Nasdaq: CPBY ) (,China Information Security,,...tware developer, systems,integrator and full-servi...ented Medical Case Statistics Software has been se...
...YORK, March 19 The Department of Pain Medicine ...a 2009 winner of the American Pain Society,s Cente...all number of pain centers for excellence and inno...taining a team of professionals able to provide ou...
...ANDRIA, Va., March 19 Together Rx Access(R), a pr...e nation,s leading pharmaceutical companies, annou...ibility income levels to help even more uninsured ...ent of uninsured Americans will now be eligible fo...
... According to a recent survey ...astic Surgery, the number of cosmetic procedures p...n 2008. In Maryland, Plastic Surgery Services&r...eb) March 19, 2009 -- Plastic Surgery Services has...
Other Medicine News:Health News:Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot 2Health News:Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot 3Health News:Clean Spa Technologies USA Adopts GeniJet(TM) Plus Hydrotherapy System with Built-In Ionizer - Sets Industry Standard for Pedicure Hygiene 2Health News:China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract 2Health News:China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract 3Health News:China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract 4Health News:The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society 2Health News:Together Rx Access(R) Program Expands Eligibility Criteria, Responds to Challenging Economic Times 2Health News:Together Rx Access(R) Program Expands Eligibility Criteria, Responds to Challenging Economic Times 3Health News:Together Rx Access(R) Program Expands Eligibility Criteria, Responds to Challenging Economic Times 4Health News:Hagerstown Cosmetic Surgeon Weathers the Current Economic Storm Despite the Sharp Decline in the Number of Cosmetic Surgeries Performed Nationwide 2
...ioneer in the design and developmerit of systems f... D.O.R.C. is pleased to present its latest system ...ion in one compact system. The D.O.R.C. VFI/VFE sy...ds, such as silicone oil, with viscosities of up t...
...O.R.C. HEXON Illumination System provides the brig...ith one remarkable difference: HEXON utilizes a me... of high quality illumination. This exceptional il...ich is well suited for vitreoretinal surgery.,D.O....
...doProbe handpieces, used for endophotocoagulation ...ve aspiration, 25 gauge, and illuminating models. ...st with uncompromised laser treatment of intravitr...tic cables that are flexible and convenient to use...
EL401 Manual Washer
Medicine Products: